Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06684769Not ApplicableRecruiting

A Chitosan Brush and Enamel Matrix Derivative for Non-surgical Treatment of Furcations

Role: collaborator

NCT03373448Not ApplicableCompleted

Treatment of Mild to Moderate Peri-implantitis Using an Oscillating Chitosan Device

Role: lead

NCT04173156Not ApplicableCompleted

Treatment of Advanced Periodontitis Using an Oscillating Chitosan Device Versus Regular Curettes Alone

Role: lead

All 3 trials loaded